Related Experiment Video
Updated: Jul 17, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
A unique microglia subset associated with aggressive α-synucleinopathy uncovered in a rapidly progressive multiple
Dai Matsuse1, Hiroo Yamaguchi2, Masaya Harada1
1Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Abstract:
Multiple system atrophy (MSA) is a progressive and fatal α-synucleinopathy characterized by α-synuclein-positive (α-syn+) glial cytoplasmic inclusions in oligodendrocytes. The cerebellar variant (MSA-C) primarily affects olivopontocerebellar fibers, resulting in extensive demyelination and glial activation. To model this pathology, we developed a Tet-Off-based MSA-C mouse model with oligodendrocyte-specific overexpression of human A53T α-syn. Upon doxycycline withdrawal at 8 weeks of age, mice developed progressive cerebellar ataxia by 26 weeks and succumbed by 30 weeks. These mice exhibited severe demyelination and marked activation of microglia and astroglia in the brainstem and cerebellum, along with widespread propagation of α-syn oligomers and phosphorylated α-syn (p-α-syn) aggregates in oligodendrocytes, astrocytes, and neurons. Single-cell RNA sequencing of CD11b+ cells from the brain and spinal cord identified a distinct microglial cluster expressing Toll-like receptor 2 (Tlr2), transglutaminase 2 (Tgm2), arginase-1, macrophage scavenger receptor-1 (Msr1), inflammatory genes (such as Nfkbia, Nfkbiz, and Il1b), and chemokines (including Ccl3, Ccl4, and Ccl12). These microglia were located adjacent to p-α-syn aggregates and were distinct from previously described protective disease-associated microglia and border-associated macrophages. TLR2- and TGM2+Iba1+ microglia were particularly enriched in demyelinating lesions. Prophylactic administration of the CSF1R inhibitor BLZ945 exacerbated motor deficits and demyelination, significantly increasing this microglial population. Similarly, MSR1+ and CD68+ microglia/macrophages were observed in early pontocerebellar lesions of six human MSA-C autopsy cases. These findings suggest that this pro-inflammatory microglia subset plays a central role in disease progression and may represent a promising therapeutic target for modifying the course of MSA-C and related synucleinopathies.
Insights
A new mouse model of Multiple System Atrophy-Cerebellar (MSA-C) reveals pro-inflammatory microglia driving disease progression. Targeting these specific microglia offers a potential therapeutic strategy for MSA-C and related synucleinopathies.
Area of Science:
- Neuroscience
- Neuroimmunology
- Pathology
Background:
- Multiple system atrophy (MSA) is a fatal neurodegenerative disease characterized by alpha-synuclein aggregates.
- The cerebellar variant (MSA-C) involves demyelination and glial activation in specific brain regions.
- Existing models do not fully recapitulate MSA-C pathology and neuroinflammation.
Purpose of the Study:
- To develop and characterize a novel mouse model for MSA-C.
- To investigate the role of microglia in MSA-C pathogenesis.
- To identify potential therapeutic targets for MSA-C.
Main Methods:
- Development of a Tet-Off inducible mouse model overexpressing human A53T alpha-synuclein in oligodendrocytes.
- Phenotypic analysis including behavioral testing, histology, and immunohistochemistry.
- Single-cell RNA sequencing of immune cells to identify microglial subtypes.
- Pharmacological inhibition of CSF1R to assess microglial role.
Main Results:
- The developed mouse model recapitulated key features of MSA-C, including ataxia, demyelination, and alpha-synuclein pathology.
- Single-cell sequencing identified a pro-inflammatory microglial subset (TLR2+, TGM2+) associated with alpha-synuclein aggregates and demyelination.
- Inhibition of CSF1R exacerbated disease, suggesting a detrimental role for this microglial population.
- Similar microglial populations were found in human MSA-C autopsy cases.
Conclusions:
- The novel MSA-C mouse model effectively mimics human disease pathology and neuroinflammation.
- A specific subset of pro-inflammatory microglia plays a critical role in MSA-C progression.
- Targeting these microglia represents a promising therapeutic avenue for MSA-C and related synucleinopathies.
Related Concept Videos
Neural Regulation
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology
Parkinson Disease ll: Pathophysiology

